Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Return on Assets (2020 - 2025)

Historic Return on Assets for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to 0.42%.

  • Relay Therapeutics' Return on Assets fell 200.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.39% for FY2024, which is 400.0% down from last year.
  • According to the latest figures from Q3 2025, Relay Therapeutics' Return on Assets is 0.42%, which was down 200.0% from 0.41% recorded in Q2 2025.
  • In the past 5 years, Relay Therapeutics' Return on Assets ranged from a high of 0.09% in Q1 2021 and a low of 0.43% during Q4 2021
  • Over the past 5 years, Relay Therapeutics' median Return on Assets value was 0.38% (recorded in 2021), while the average stood at 0.35%.
  • Per our database at Business Quant, Relay Therapeutics' Return on Assets tumbled by -4000bps in 2021 and then surged by 1800bps in 2022.
  • Quarter analysis of 5 years shows Relay Therapeutics' Return on Assets stood at 0.43% in 2021, then skyrocketed by 41bps to 0.26% in 2022, then crashed by -53bps to 0.39% in 2023, then rose by 4bps to 0.37% in 2024, then dropped by -13bps to 0.42% in 2025.
  • Its last three reported values are 0.42% in Q3 2025, 0.41% for Q2 2025, and 0.4% during Q1 2025.